MyUltimateBiz Work from Home

Posts Tagged ‘Clinical’

Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation of Phase I Clinical Trial of ASG-5ME for …
BOTHELL, Wash.—-Seattle Genetics, Inc. and Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of metastatic pancreatic cancer.

Read more on Business Wire via Yahoo! Finance

Related Blogs

• SiteGround Selects The Planet Server Cloud – Business Wire (press …
• Angelina Jolie scolds Maddox in Tokyo airport | HollywoodNews.com
• Seattle Genetics Inc. (SGEN) goes negative by breaking below …
• Pancreatic Cancer Drug: Seattle Genetics and Partner Agensys Start …
• More Information on Research and Clinical Trials « Autism Speaks …

Johnson & Johnson Pharmaceutical Research & Development Reports Phase 2b Clinical Trial Results Evaluating …
ORLANDO, Fla., June 26 /PRNewswire/ — Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Read more on redOrbit

Related Blogs

• Clinical test results affect several stocks
• Intellectual Property Watch » Blog Archive » Pharma Industry To …
• Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial …
• Johnson & Johnson No More Tangles Spray | Chasing Babies
• !: Latest Headlines PRNewswire Brasil – McDonald's USA faz …

Mass. Eye and Ear receives NEI grant renewal for ‘growing’ clinical/scientists
( Massachusetts Eye and Ear Infirmary ) The Massachusetts Eye and Ear Infirmary, Harvard Medical School department of ophthalmology, has been awarded a grant renewal from the National Institutes of Health, National Eye Institute, to recruit, train and support first-rate clinician scientists to promote translational and clinical research into cures for eye disease.

Read more on EurekAlert!

hi! I am a high school student who lives in New York and is deciding to do a course through my high school (Boces program). But I am not sure which course i should take “Clinical Medical Assisting or Practical Nursing”.

I plan on becoming some sort of doctor one day(not sure maybe an ER doctor or a general doctor). so i thought that this would be a good start on getting involved in the medical field.

The Clinical Medical Assisting course provides me with the basic training in the area of plebotomy, EKG, medical terminology, first aid/CPR, and medical assisting. It also enables me to become nationally certified by American Association of Allied Health Professionals (AAAHP).

The Practical Nursing course provides me with the basic nursing skills necessary to care for patients based on the principles of the biological physical and social sciences and includes a 100-hour clinical experience in affiliate hospitals. It also allows me to have a full-time clinical experience, so i can be eligible to take the New York State Board examination for licensure as a Licensed Practical Nurse (L. P. N. ).

But i am not sure which course i should take. Both sound great but which one is better for me.

Please Help Me Decide!!!!!!!!!!!!!!

Clinical Trial Test Helps Measure Effectiveness of Treatment for Patients with Metastatic Cancer
To see if CellSearch could predict patient response to therapy earlier than traditional measures. Patients could be spared the expense and unpleasant side effects of continuing with an ineffective treatment course.

Read more on Newswise

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily
Oncothyreon Inc. today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., have temporarily suspended the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine). The suspension is the result of a suspected unexpected serious adverse reaction in a patient with multiple myeloma participating in an …

Read more on News-Medical-Net

Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.

Read more on Business Wire via Yahoo! Finance

Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.

Read more on Business Wire via Yahoo! Finance